Clinical Trials Directory

We are doing this study to learn more about why some people develop pain syndromes after a stroke. We want to find out if certain brain areas, like the ventral posterior lateral nucleus of the thalamus and its connections, are linked to this pain.

We are doing this study to find the most effective, safe dose of an experimental drug called pocenbrodib (the study drug). We want to see how it works when it is given by itself and also when it is given with other drugs already approved for the treatment in people with metastatic castration-resistant prostate cancer (mCRPC).

We are doing this study to test a program that is being developed by nurses to help patients with HER2+ metastatic breast cancer manage their treatment with three drugs typically used for this diagnosis: tucatinib, trastuzumab, and capecitabine. The program's goal is to help patients manage symptoms and provide resources to improve their quality of life.

1. Complete 1 short online survey [questionnaire] (5 minutes) 2. Complete 1 interview (about 1 hour)

People who join this study will first complete questionnaires and have a short evaluation with a doctor who specializes in movement disorders. They will then take part in a Parkinson disease improv workshop that meets once a week for four weeks. Each workshop lasts about 90 minutes. After the workshops are finished, participants will complete the questionnaires again and have another short evaluation with the doctor. Researchers will use this information to see how the improv program may affect movement, symptoms, and quality of life.